bizjournals.com Health Care:Pharmaceuticals headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.AdventHealth plans expansion at Celebration hospital
The growth would make it among the largest hospitals in the region. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Ryan Lynch Source Type: news
How MedStar aims to keep discharged patients from returning to hospital
A new partnership with a Denver firm could prevent readmissions, easing the burden on hospital staff. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Sara Gilgore Source Type: news
Kettering Health opens new clinic in historic Dayton home
Kettering Health recently announced the opening of its newest center in the former home of Charles Kettering, the namesake for the city and one of the largest health systems in the Dayton region. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Lauren Steen Source Type: news
Private equity in health care: studies highlight 'life-or-death consequences'
Private equity ownership of medical practices can be a boon for investors. But a handful of studies show it may have 'life-or-death consequences' patients. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
Vertex CEO's compensation crosses $20M threshold in 2023
Reshma Kewalramani's 2023 compensation positions her to likely be the top-paid female CEO in the state, according to Business Journal research. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Jess Aloe Source Type: news
Private equity and corporate ownership in Oregon health care are surging — and worrying critics
Corporate ownership of health care has raised a code red. Here's why doctors fear having to 'fight the good fight or look at private equity.' (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
State awards $10M in student loan repayment to mental health workers
The grants are part of the MA Repay Program, which is providing student loan forgiveness to build up the Massachusetts healthcare workforce. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Cassie McGrath Source Type: news
AskBio co-founder Jude Samulski steps down, successor named
The groundbreaking co-founder of one of North Carolina's most well-known gene therapy companies has left his longtime role in the C-suite. He's replaced by a prominent executive from Eli Lilly and Co. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news
Thermo Fisher CEO's compensation dropped by 33% last year
Marc Casper, the CEO of one of the state's largest public companies, saw his total compensation fall by about $10 million in value last year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Jess Aloe Source Type: news
Ponte Vedra-based Cadrenal Therapeutics receives second FDA orphan drug designation
Cadrenal received a Orphan Drug Designation for its reversible anticoagulant tecarfarin (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: James Cannon Source Type: news
A look at Baptist University's osteopathic medical school's $34 million renovation
The school is scheduled to welcome its first class this fall to its new facility in the Medical District. The building underwent $34 million in renovations that transformed the space with new tech, equipment, and furniture. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2024 Category: Pharmaceuticals Authors: Wendy Guzm án Source Type: news
Top Senate Dem wants private equity out of healthcare
A powerful Senate Democrat wants to "take for-profit, equity-based companies out of the health care system," a bold declaration as state policymakers look to contain the crisis surrounding the floundering Steward Health Care network and its hospitals across Massachusetts. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 8, 2024 Category: Pharmaceuticals Authors: Colin A. Young Source Type: news
Peninsula company's fix for deviated septum greenlighted by FDA
The 16-person company looks to slowly commercialize its system for fixing minor nasal septal deviations and raise a $25 million to $30 million Series B round. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 8, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Oracle Chairman Larry Ellison will have a fireside chat with Bill Frist
This won't be the first fireside chat that Larry Ellison and Bill Frist will have had in Greater Nashville. This time, Ellison — the world's fifth-wealthiest person — will be underlining his company's health care ambitions at an industry summit Oracle's hosting in Midtown. Here's what we know. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 8, 2024 Category: Pharmaceuticals Authors: Adam Sichko Source Type: news
Clover Health Investments threatened with Nasdaq banishment
Clover Health Investments could be delisted from the Nasdaq. Here's why and how long they have to make corrections. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 8, 2024 Category: Pharmaceuticals Authors: Nikki Ross Source Type: news
